These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Recombinant hirudin as an anticoagulant during cardiac operations: experiments in a pig model. Riess FC; Pötzsch B; Behr I; Jäger K; Rössing R; Bleese N; Schaper W; Müller-Berghaus G Eur J Cardiothorac Surg; 1997 Apr; 11(4):739-45. PubMed ID: 9151047 [TBL] [Abstract][Full Text] [Related]
45. Effect of high or low protamine dosing on postoperative bleeding following heparin anticoagulation in cardiac surgery. A randomised clinical trial. Meesters MI; Veerhoek D; de Lange F; de Vries JW; de Jong JR; Romijn JW; Kelchtermans H; Huskens D; van der Steeg R; Thomas PW; Burtman DT; van Barneveld LJ; Vonk AB; Boer C Thromb Haemost; 2016 Aug; 116(2):251-61. PubMed ID: 27277211 [TBL] [Abstract][Full Text] [Related]
46. The influence of aprotinin and tranexamic acid on platelet function and postoperative blood loss in cardiac surgery. Mengistu AM; Röhm KD; Boldt J; Mayer J; Suttner SW; Piper SN Anesth Analg; 2008 Aug; 107(2):391-7. PubMed ID: 18633013 [TBL] [Abstract][Full Text] [Related]
47. Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial. van der Linden J; Lindvall G; Sartipy U Circulation; 2005 Aug; 112(9 Suppl):I276-80. PubMed ID: 16159831 [TBL] [Abstract][Full Text] [Related]
54. A single dose of aprotinin prevents platelet hyporeactivity after coronary artery bypass graft surgery. Szczeklik W; Morawski W; Sanak M; Jakieła B; Bolkowski M; Cisowski M; Szczeklik M; Bochenek A; Musiał J Pol Arch Med Wewn; 2010 Sep; 120(9):321-7. PubMed ID: 20864904 [TBL] [Abstract][Full Text] [Related]
55. Inhaled prostacyclin and platelet function after cardiac surgery and cardiopulmonary bypass. Haraldsson A; Kieler-Jensen N; Wadenvik H; Ricksten SE Intensive Care Med; 2000 Feb; 26(2):188-94. PubMed ID: 10784307 [TBL] [Abstract][Full Text] [Related]
56. Perioperative course and recovery after heparin-coated cardiopulmonary bypass: low-dose versus high-dose heparin management. Weiss BM; von Segesser LK; Turina MI; Seifert B; Pasch T J Cardiothorac Vasc Anesth; 1996 Jun; 10(4):464-70. PubMed ID: 8776638 [TBL] [Abstract][Full Text] [Related]
57. Does continuous heparinization influence platelet function in the intensive care patient? Boldt J; Müller M; Rothe A; Lenzen P; Hempelmann G Intensive Care Med; 1997 May; 23(5):567-73. PubMed ID: 9201530 [TBL] [Abstract][Full Text] [Related]
58. Early platelet recovery following cardiac surgery with cardiopulmonary bypass. Van Poucke S; Stevens K; Wetzels R; Kicken C; Verhezen P; Theunissen M; Kuiper G; van Oerle R; Henskens Y; Lancé M Platelets; 2016 Dec; 27(8):751-757. PubMed ID: 27164510 [TBL] [Abstract][Full Text] [Related]
59. Low-dose heparin versus full-dose heparin with high-dose aprotinin during cardiopulmonary bypass. A preliminary report. von Segesser LK; Garcia E; Turina MI Tex Heart Inst J; 1993; 20(1):28-32. PubMed ID: 7685221 [TBL] [Abstract][Full Text] [Related]
60. Effects of aprotinin during cardiopulmonary bypass in patients treated with acetylsalicylic acid. Ivert T; Intonti M; Stain-Malmgren R; Dumitrescu A; Blombäck M Scand Cardiovasc J; 1998; 32(5):289-95. PubMed ID: 9835004 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]